Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can slow hair growth in adult monkeys, but a blocker called RU 58841 can counteract this and potentially help hair regrow.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Ethosomes could improve how well skin treatments work, but more research is needed on their safety and stability.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The document concludes that proper recognition and treatment of skin appendage disorders are important for management.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

The study found that the enzyme linked to acne is present in the same areas of both acne-affected and normal skin.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Gastric bypass surgery improved a woman's hormonal disorder without the need for medication.

Platelet-derived products help regenerate tissue and are used in various skin and hair treatments.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Fullerenes show potential in skin care but need more safety research.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.